Male gender
|
1108 (67%)
|
834 (65%)
|
730 (64.8%)
|
Age (median [Q1;Q3], years)
|
65 [55;76]
|
64 [53;75]
|
64 [53;74]
|
0–54 years olda
|
394 (23.7%)
|
345 (26.8%)
|
322 (28.6%)
|
55–64 years old
|
409 (24.6%)
|
327 (25.4%)
|
290 (25.7%)
|
65–75 years old
|
424 (25.5%)
|
316 (24.6%)
|
277 (24.6%)
|
≥ 76 years old
|
438 (26.3%)
|
298 (23.2%)
|
238 (21.1%)
|
Alcohol
|
429 (25.8%)
|
332 (25.8%)
|
289 (25.6%)
|
Tobacco
|
590 (35.4%)
|
476 (37.0%)
|
415 (36.8%)
|
No comorbidities
|
86 (5.1%)
|
82 (6.4%)
|
79 (7.0%)
|
At least one
|
1579 (94.8%)
|
1204 (93.6%)
|
1048 (93.0%)
|
Asplenia/hyposplenia
|
12 (0.7%)
|
9 (0.7%)
|
6 (0.5%)
|
Cancers / hemopathy
|
497 (29.8%)
|
347 (27.0%)
|
278 (24.7%)
|
Auto-immune disorders
|
146 (8.8%)
|
111 (8.6%)
|
97 (8.6%)
|
Organ transplant recipientb
|
267 (16.0%)
|
194 (15.1%)
|
157 (13.9%)
|
HIV
|
32 (1.9%)
|
21 (1.6%)
|
19 (1.7%)
|
Diabetes mellitus
|
415 (24.9%)
|
321 (25.0%)
|
275 (24.4%)
|
Chronic cardiac failure
|
518 (31.1%)
|
379 (29.5%)
|
297 (26.4%)
|
Chronic respiratory diseasesc
|
861 (51.2%)
|
688 (53.5%)
|
594 (52.7%)
|
Renal diseasesd
|
239 (14.4%)
|
172 (13.4%)
|
140 (12.4%)
|
Chronic renal insufficiency
|
202 (12.1%)
|
146 (11.4%)
|
118 (10.5%)
|
Liver diseasese
|
272 (16.3%)
|
170 (13.2%)
|
142 (12.6%)
|
Cirrhosis
|
165 (9.9%)
|
106 (8.2%)
|
88 (7.8%)
|
Liver failure
|
118 (7.1%)
|
61 (4.7%)
|
49 (4.3%)
|
SAPSII
|
48 (± 19)
|
45 (± 17)
|
44 (± 17)
|
Mechanical ventilation
|
1103 (66.2%)
|
789 (61.4%)
|
706 (62.6%)
|
Noninvasive ventilation
|
987 (59.3%)
|
818 (63.6%)
|
708 (62.8%)
|
Vasopressor use
|
1032 (62.0%)
|
728 (56.6%)
|
640 (56.8%)
|
Renal replacement therapy
|
227 (13.6%)
|
105 (8.2%)
|
94 (8.3%)
|
Length of initial stay in hospital (days)
|
23 (± 22)
|
24 (± 21)
|
24 (± 21)
|
Length of stay in ICU (days)
|
13 (± 16)
|
12 (± 15)
|
12 (± 15)
|